Yamaji Koutaro, Kai Keita, Komukai Sho, Koga Hiroki, Ide Takao, Kawaguchi Atsushi, Noshiro Hirokazu, Aishima Shinichi
Department of Surgery, Saga University Faculty of Medicine, Saga 849-8501, Japan.
Department of Pathology & Microbiology, Saga University Faculty of Medicine, Saga 849-8501, Japan.
Hepatobiliary Surg Nutr. 2018 Dec;7(6):443-453. doi: 10.21037/hbsn.2018.10.01.
We sought to clarify the prevalence of occult hepatitis B virus (HBV) infection (OBI) and to determine whether OBI affects the surgical outcomes in curatively resected Japanese patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).
A total of 257 patients with HCV-related HCC who underwent curative surgical resection were enrolled. All enrolled patients were serologically negative for HBV surface antigen and positive for HCV antibody. DNA was extracted from formalin-fixed paraffin-embedded liver tissue. OBI was determined by the HBV-DNA amplification of at least two different sets of primers by TaqMan real-time polymerase chain reaction. Surgical outcomes were evaluated according to overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS).
OBI was identified in 15 of the 257 (5.8%) cases. In the multivariate analyses, the factors significantly correlated with OS were BMI >25 (P=0.0416), portal vein invasion (P=0.0065), and multiple tumors (P=0.0064). The only factor significantly correlated with DSS was T-stage (P=0.0275). The factors significantly correlated with DFS were liver fibrosis (P=0.0017) and T-stage (P=0.0001). The status of OBI did not show any significant correlation with OS, DSS or DFS, but a weak association with DSS (P=0.0603) was observed.
The prevalence of OBI was 5.8% in 257 cases of HCV-related HCC. Although a weak association between DSS and OBI was observed, and statistical analyses were limited by small number of OBI cases, no significant correlation between OBI and surgical outcomes was detected.
我们试图阐明隐匿性乙型肝炎病毒(HBV)感染(OBI)的患病率,并确定OBI是否会影响日本丙型肝炎病毒(HCV)相关肝细胞癌(HCC)患者手术切除后的疗效。
共纳入257例行根治性手术切除的HCV相关HCC患者。所有纳入患者的HBV表面抗原血清学检测均为阴性,HCV抗体检测均为阳性。从福尔马林固定石蜡包埋的肝组织中提取DNA。采用TaqMan实时聚合酶链反应,通过至少两组不同引物的HBV-DNA扩增来确定OBI。根据总生存期(OS)、疾病特异性生存期(DSS)和无病生存期(DFS)评估手术疗效。
257例患者中有15例(5.8%)被诊断为OBI。在多因素分析中,与OS显著相关的因素为体重指数>25(P=0.0416)、门静脉侵犯(P=0.0065)和多发肿瘤(P=0.0064)。与DSS显著相关的唯一因素为T分期(P=0.0275)。与DFS显著相关的因素为肝纤维化(P=0.0017)和T分期(P=0.0001)。OBI状态与OS、DSS或DFS均无显著相关性,但观察到与DSS有较弱的关联(P=0.0603)。
在257例HCV相关HCC患者中,OBI的患病率为5.8%。尽管观察到DSS与OBI之间存在较弱的关联,且由于OBI病例数量较少,统计分析受到限制,但未检测到OBI与手术疗效之间存在显著相关性。